vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and CBAK Energy Technology, Inc. (CBAT). Click either name above to swap in a different company.
Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $58.8M, roughly 1.3× CBAK Energy Technology, Inc.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -12.5%, a 2.9% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs -16.8%). Over the past eight quarters, CBAK Energy Technology, Inc.'s revenue compounded faster (-0.0% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
BIOX vs CBAT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $58.8M |
| Net Profit | $-7.4M | $-7.4M |
| Gross Margin | 46.8% | 7.3% |
| Operating Margin | 9.3% | -13.6% |
| Net Margin | -9.6% | -12.5% |
| Revenue YoY | -16.8% | 131.8% |
| Net Profit YoY | -20.2% | -63.6% |
| EPS (diluted) | $-0.12 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $58.8M | ||
| Q3 25 | $77.6M | $60.9M | ||
| Q2 25 | — | $40.5M | ||
| Q1 25 | $60.6M | $34.9M | ||
| Q4 24 | $98.8M | $25.4M | ||
| Q3 24 | $93.3M | $44.6M | ||
| Q2 24 | — | $47.8M | ||
| Q1 24 | $84.0M | $58.8M |
| Q4 25 | — | $-7.4M | ||
| Q3 25 | $-7.4M | $2.7M | ||
| Q2 25 | — | $-3.1M | ||
| Q1 25 | $-1.6M | $-1.6M | ||
| Q4 24 | $605.2K | $-4.5M | ||
| Q3 24 | $-6.2M | $17.6K | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | $9.8M | $9.8M |
| Q4 25 | — | 7.3% | ||
| Q3 25 | 46.8% | 8.0% | ||
| Q2 25 | — | 11.0% | ||
| Q1 25 | 39.4% | 13.7% | ||
| Q4 24 | 42.0% | 13.1% | ||
| Q3 24 | 40.2% | 15.6% | ||
| Q2 24 | — | 26.6% | ||
| Q1 24 | 50.8% | 31.9% |
| Q4 25 | — | -13.6% | ||
| Q3 25 | 9.3% | -6.6% | ||
| Q2 25 | — | -8.7% | ||
| Q1 25 | 1.5% | -8.2% | ||
| Q4 24 | 14.5% | -26.0% | ||
| Q3 24 | 2.5% | -1.9% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | 15.7% | 17.4% |
| Q4 25 | — | -12.5% | ||
| Q3 25 | -9.6% | 4.4% | ||
| Q2 25 | — | -7.6% | ||
| Q1 25 | -2.6% | -4.5% | ||
| Q4 24 | 0.6% | -17.8% | ||
| Q3 24 | -6.6% | 0.0% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | 11.6% | 16.7% |
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.12 | $0.03 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | $-0.02 | $-0.02 | ||
| Q4 24 | $0.00 | $-0.05 | ||
| Q3 24 | $-0.10 | $0.00 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | $0.14 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $8.3M |
| Total DebtLower is stronger | — | $4.1M |
| Stockholders' EquityBook value | $288.3M | $112.7M |
| Total Assets | $734.9M | $426.2M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.3M | ||
| Q3 25 | $15.5M | $10.5M | ||
| Q2 25 | — | $45.7M | ||
| Q1 25 | $38.5M | $9.6M | ||
| Q4 24 | $29.2M | $11.0M | ||
| Q3 24 | $32.3M | $24.2M | ||
| Q2 24 | — | $44.1M | ||
| Q1 24 | $16.4M | $23.8M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $4.8M | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | — | $4.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $112.7M | ||
| Q3 25 | $288.3M | $121.4M | ||
| Q2 25 | — | $118.2M | ||
| Q1 25 | $345.0M | $120.8M | ||
| Q4 24 | $346.3M | $121.7M | ||
| Q3 24 | $346.0M | $131.2M | ||
| Q2 24 | — | $126.6M | ||
| Q1 24 | $348.5M | $120.9M |
| Q4 25 | — | $426.2M | ||
| Q3 25 | $734.9M | $363.9M | ||
| Q2 25 | — | $333.1M | ||
| Q1 25 | $798.2M | $311.5M | ||
| Q4 24 | $835.2M | $302.2M | ||
| Q3 24 | $827.3M | $293.5M | ||
| Q2 24 | — | $279.6M | ||
| Q1 24 | $836.1M | $286.5M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $29.8M |
| Free Cash FlowOCF − Capex | — | $16.1M |
| FCF MarginFCF / Revenue | — | 27.3% |
| Capex IntensityCapex / Revenue | — | 23.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $29.8M | ||
| Q3 25 | $14.4M | $14.6M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | $23.3M | $-9.6M | ||
| Q4 24 | $-5.4M | $9.6M | ||
| Q3 24 | $5.2M | $19.7M | ||
| Q2 24 | — | $2.9M | ||
| Q1 24 | $-17.4M | $7.4M |
| Q4 25 | — | $16.1M | ||
| Q3 25 | — | $6.0M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-22.3M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | — | $16.5M | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $-454.0K |
| Q4 25 | — | 27.3% | ||
| Q3 25 | — | 9.9% | ||
| Q2 25 | — | 10.2% | ||
| Q1 25 | — | -63.9% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 5.2% | ||
| Q1 24 | — | -0.8% |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 14.1% | ||
| Q2 25 | — | 23.8% | ||
| Q1 25 | — | 36.3% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 13.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.51× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | 1115.72× | ||
| Q2 24 | — | 0.46× | ||
| Q1 24 | -1.78× | 0.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
